Lista de obras - Adrian F. Daly - Dominio Público Uruguay

A Familial Non Medullary Thyroid Carcinoma (FNMTC) : a clinical and genetic update

artículo científico publicado en 2016

A bittersweet symphony

artículo científico publicado en 2014

A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues.

artículo científico publicado en 2017

A novel inactivating mutation of the LH/chorionic gonadotrophin receptor with impaired membrane trafficking leading to Leydig cell hypoplasia type 1.

artículo científico publicado en 2015

A vital region for human glycoprotein hormone trafficking revealed by an LHB mutation.

artículo científico publicado en 2016

AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center

artículo científico publicado en 2019

AIP mutations and gigantism.

artículo científico publicado en 2017

Absence of hypogonadism in a male patient with a giant prolactinoma: a clinical paradox.

artículo científico publicado en 2007

Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database.

artículo científico publicado en 2017

Adipsic diabetes insipidus revealing a bifocal intracranial germinoma.

artículo científico publicado en 2017

Aggressive pituitary adenomas occurring in young patients in a large Polynesian kindred with a germline R271W mutation in the AIP gene.

artículo científico publicado en 2009

Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome

artículo científico publicado en 2015

Alcoholic ketoacidosis presenting as diabetic ketoacidosis

scientific article published on 01 July 1999

An overview of the epidemiology and genetics of acromegaly.

artículo científico publicado en 2005

Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.

artículo científico publicado en 2007

Breast cancer in a male-to-female transsexual patient with a BRCA2 mutation

artículo científico publicado en 2016

Cellular effects of AP102, a somatostatin analog with balanced affinities for the hSSTR2 and hSSTR5 receptors

artículo científico publicado en 2018

Challenges and controversies in the treatment of prolactinomas

scientific article published on 19 September 2014

Characteristics of familial isolated pituitary adenomas

article

Characterization of GPR101 transcript structure and expression patterns

artículo científico publicado en 2016

Clinical and Molecular Update on Genetic Causes of Pituitary Adenomas

artículo científico publicado en 2020

Clinical and genetic aspects of familial isolated pituitary adenomas

artículo científico publicado en 2012

Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.

artículo científico publicado en 2015

Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study

artículo científico publicado en 2010

Clinical characterization of familial isolated pituitary adenomas.

artículo científico publicado en 2006

Combined treatment with octreotide LAR and pegvisomant in patients with pituitary gigantism: clinical evaluation and genetic screening.

artículo científico publicado en 2016

Comment on "Hypogonadotrophic hypogonadism due to a mutation in the luteinizing hormone β-subunit gene"

artículo científico publicado en 2017

Compound heterozygous mutations in the luteinizing hormone receptor signal peptide causing 46,XY disorder of sex development

scientific article published on 01 August 2019

Current and future perspectives on recombinant growth hormone for the treatment of obesity

scientific article published on 01 January 2008

Cytokine dysregulation, inflammation and well-being.

artículo científico publicado en 2005

Deletion of exons 1–3 of the MEN1 gene in a large Italian family causes the loss of menin expression

article

Desloratadine for allergic rhinitis

scientific article published on 01 March 2006

Does the nadir growth-hormone level predict response to somatostatin-analogue therapy?

artículo científico publicado en 2006

Effect of AP102, a subtype 2 and 5 specific somatostatin analog, on glucose metabolism in rats.

artículo científico publicado en 2017

Epidemiology and Management Challenges in Prolactinomas

scientific article published on 07 February 2019

Erratum to: Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia

artículo científico publicado en 2017

Excellent response to pasireotide therapy in an aggressive and dopamine-resistant prolactinoma

scientific article published on 01 August 2019

Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cells.

artículo científico publicado en 2016

Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.

artículo científico publicado en 2009

Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene ⬇️

artículo científico publicado el 31 de enero de 2013

Familial pituitary adenomas.

artículo científico publicado en 2009

Familial pituitary tumor syndromes.

scientific article published on July 2011

GHRH excess and blockade in X-LAG syndrome.

artículo científico publicado en 2015

GPR101 Mutations are not a Frequent Cause of Congenital Isolated Growth Hormone Deficiency

artículo científico publicado en 2016

GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq/11

scientific article published on 21 September 2020

Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.

artículo científico publicado en 2013

Genetic factors in the development of pituitary adenomas.

artículo científico publicado en 2009

Genetic susceptibility in pituitary adenomas: from pathogenesis to clinical implications

scientific article published on 01 March 2011

Genetic, molecular and clinical features of familial isolated pituitary adenomas.

scientific article published on 29 April 2009

Genetics of Cushing's syndrome.

artículo científico publicado en 2010

Genética en adenomas hipofisarias: ¿qué, cómo y a quién?

scientific article published on 01 February 2019

Gigantism Remains a Clinical Challenge

artículo científico publicado en 2015

Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation

artículo científico publicado en 2014

Gigantism, acromegaly, and GPR101 mutations

artículo científico publicado en 2015

Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs.

artículo científico publicado en 2005

High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.

artículo científico publicado en 2011

High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium

artículo científico publicado en 2006

Hormonal and biochemical normalization and tumor shrinkage induced by anti-parathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma.

artículo científico publicado en 2004

Hypogonadism in a patient with a mutation in the luteinizing hormone beta-subunit gene.

artículo científico publicado en 2004

Long-term remission of disseminated parathyroid cancer following immunotherapy

scientific article published on 28 November 2019

MANAGEMENT OF ENDOCRINE DISEASE: Pituitary 'incidentaloma': neuroradiological assessment and differential diagnosis

artículo científico publicado en 2016

Management of acromegaly

artículo científico publicado en 2010

McCune-Albright syndrome: a detailed pathological and genetic analysis of disease effects in an adult patient

artículo científico publicado en 2014

Mutations in theAryl Hydrocarbon Receptor Interacting ProteinGene Are Not Highly Prevalent among Subjects with Sporadic Pituitary Adenomas

article

Mutations of calcium-sensing receptor gene: two novel mutations and overview of impact on calcium homeostasis

artículo científico publicado en 2011

Old phenotype and new genotypes. Pituitary adenomas

artículo científico publicado en 2015

Oral vitamin C attenuates acute ischaemia-reperfusion injury in skeletal muscle.

artículo científico publicado en 2001

Oral vitamin C reduces the injury to skeletal muscle caused by compartment syndrome.

artículo científico publicado en 2004

Overview of genetic testing in patients with pituitary adenomas.

artículo científico publicado en 2012

Paleogenetic study of ancient DNA suggestive of X-linked acrogigantism

artículo científico publicado en 2017

Pancreatic Neuroendocrine Neoplasm Associated with a Familial MAX Deletion

artículo científico publicado en 2020

Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions

scientific article published on 13 March 2018

Pituitary Disease in AIP Mutation-Positive Familial Isolated Pituitary Adenoma (FIPA): A Kindred-Based Overview

artículo científico publicado en 2020

Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences.

artículo científico publicado en 2015

Pituitary adenomas in young patients: when should we consider a genetic predisposition?

scientific article published on 01 November 2009

Pituitary gigantism: Causes and clinical characteristics

artículo científico publicado en 2015

Predictors and rates of treatment-resistant tumor growth in acromegaly.

artículo científico publicado en 2005

Primary hypertrophic osteoarthropathy due to a novel SLCO2A1 mutation masquerading as acromegaly

artículo científico publicado en 2017

Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients

artículo científico publicado en 2012

Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia

artículo científico publicado en 2016

Pseudomalabsorption of thyroid hormones: case report and review of the literature.

artículo científico publicado en 2007

Resistant Paediatric Somatotropinomas due to AIP Mutations: Role of Pegvisomant

artículo científico publicado en 2018

Screening for GPR101 defects in pediatric pituitary corticotropinomas

artículo científico publicado en 2016

Serum levels of soluble CD163 correlate with the inflammatory process in coeliac disease

scientific article published on 01 August 2006

Shrinkage of pituitary adenomas with pasireotide

scientific article published on 01 July 2019

Somatic and germline mutations in the pathogenesis of pituitary adenomas

scientific article published on 01 December 2019

Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects

artículo científico publicado en 2016

Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations.

artículo científico publicado en 2013

T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly

artículo científico publicado en 2016

Testicular effects of isolated luteinizing hormone deficiency and reversal by long-term human chorionic gonadotropin treatment

artículo científico publicado en 2009

The Liege Acromegaly Survey (LAS): A new software tool for the study of acromegaly ⬇️

artículo científico publicado el 9 de junio de 2012

The causes and consequences of pituitary gigantism

scientific article published on 01 December 2018

The epidemiology and management of pituitary incidentalomas

artículo científico publicado en 2007

The epidemiology of prolactinomas

artículo científico publicado en 2005

The genetics of pituitary adenomas.

artículo científico publicado en 2010

The ratio of parathyroid hormone as measured by third- and second-generation assays as a marker for parathyroid carcinoma

artículo científico publicado en 2010

The role of AIP mutations in pituitary adenomas: 10 years on.

artículo científico publicado en 2016

The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes.

artículo científico publicado en 2010

The third/second generation PTH assay ratio as a marker for parathyroid carcinoma: evaluation using an automated platform

artículo científico publicado en 2013

Transdifferentiation of Neuroendocrine Cells: Gangliocytoma Associated With Two Pituitary Adenomas of Different Lineage in MEN1.

artículo científico publicado en 2017

Treatment of pituitary tumors: somatostatin.

artículo científico publicado en 2005

Update on familial pituitary tumors: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma.

artículo científico publicado en 2009

Vitex agnus castus might enrich the pharmacological armamentarium for medical treatment of prolactinoma

artículo científico publicado en 2007

X-LAG: How did they grow so tall?

artículo científico publicado en 2017

X-linked acrogigantism syndrome: clinical profile and therapeutic responses

artículo científico publicado en 2015

[AIP mutations in familial and sporadic pituitary adenomas: local experience and review of the literature]

artículo científico publicado en 2009

[Familial pituitary adenomas].

artículo científico publicado en 2008

[Genetics of familial pituitary adenomas].

artículo científico publicado en 2009

[How do you investigate an elevated calcitonin level?]

scientific article published on 01 March 2006

[Management of prolactinoma]

artículo científico publicado en 2013

Lista de obras de Adrian F. Daly

A Familial Non Medullary Thyroid Carcinoma (FNMTC) : a clinical and genetic update

A bittersweet symphony

A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues.

A novel inactivating mutation of the LH/chorionic gonadotrophin receptor with impaired membrane trafficking leading to Leydig cell hypoplasia type 1.

A vital region for human glycoprotein hormone trafficking revealed by an LHB mutation.

AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center

AIP mutations and gigantism.

Absence of hypogonadism in a male patient with a giant prolactinoma: a clinical paradox.

Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database.

Adipsic diabetes insipidus revealing a bifocal intracranial germinoma.

Aggressive pituitary adenomas occurring in young patients in a large Polynesian kindred with a germline R271W mutation in the AIP gene.

Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome

Alcoholic ketoacidosis presenting as diabetic ketoacidosis

An overview of the epidemiology and genetics of acromegaly.

Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.

Breast cancer in a male-to-female transsexual patient with a BRCA2 mutation

Cellular effects of AP102, a somatostatin analog with balanced affinities for the hSSTR2 and hSSTR5 receptors

Challenges and controversies in the treatment of prolactinomas

Characteristics of familial isolated pituitary adenomas

Characterization of GPR101 transcript structure and expression patterns

Clinical and Molecular Update on Genetic Causes of Pituitary Adenomas

Clinical and genetic aspects of familial isolated pituitary adenomas

Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.

Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study

Clinical characterization of familial isolated pituitary adenomas.

Combined treatment with octreotide LAR and pegvisomant in patients with pituitary gigantism: clinical evaluation and genetic screening.

Comment on "Hypogonadotrophic hypogonadism due to a mutation in the luteinizing hormone β-subunit gene"

Compound heterozygous mutations in the luteinizing hormone receptor signal peptide causing 46,XY disorder of sex development

Current and future perspectives on recombinant growth hormone for the treatment of obesity

Cytokine dysregulation, inflammation and well-being.

Deletion of exons 1–3 of the MEN1 gene in a large Italian family causes the loss of menin expression

Desloratadine for allergic rhinitis

Does the nadir growth-hormone level predict response to somatostatin-analogue therapy?

Effect of AP102, a subtype 2 and 5 specific somatostatin analog, on glucose metabolism in rats.

Epidemiology and Management Challenges in Prolactinomas

Erratum to: Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia

Excellent response to pasireotide therapy in an aggressive and dopamine-resistant prolactinoma

Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cells.

Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.

Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene ⬇️

Familial pituitary adenomas.

Familial pituitary tumor syndromes.

GHRH excess and blockade in X-LAG syndrome.

GPR101 Mutations are not a Frequent Cause of Congenital Isolated Growth Hormone Deficiency

GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq/11

Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.

Genetic factors in the development of pituitary adenomas.

Genetic susceptibility in pituitary adenomas: from pathogenesis to clinical implications

Genetic, molecular and clinical features of familial isolated pituitary adenomas.

Genetics of Cushing's syndrome.

Genética en adenomas hipofisarias: ¿qué, cómo y a quién?

Gigantism Remains a Clinical Challenge

Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation

Gigantism, acromegaly, and GPR101 mutations

Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs.

High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.

High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium

Hormonal and biochemical normalization and tumor shrinkage induced by anti-parathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma.

Hypogonadism in a patient with a mutation in the luteinizing hormone beta-subunit gene.

Long-term remission of disseminated parathyroid cancer following immunotherapy

MANAGEMENT OF ENDOCRINE DISEASE: Pituitary 'incidentaloma': neuroradiological assessment and differential diagnosis

Management of acromegaly

McCune-Albright syndrome: a detailed pathological and genetic analysis of disease effects in an adult patient

Mutations in theAryl Hydrocarbon Receptor Interacting ProteinGene Are Not Highly Prevalent among Subjects with Sporadic Pituitary Adenomas

Mutations of calcium-sensing receptor gene: two novel mutations and overview of impact on calcium homeostasis

Old phenotype and new genotypes. Pituitary adenomas

Oral vitamin C attenuates acute ischaemia-reperfusion injury in skeletal muscle.

Oral vitamin C reduces the injury to skeletal muscle caused by compartment syndrome.

Overview of genetic testing in patients with pituitary adenomas.

Paleogenetic study of ancient DNA suggestive of X-linked acrogigantism

Pancreatic Neuroendocrine Neoplasm Associated with a Familial MAX Deletion

Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions

Pituitary Disease in AIP Mutation-Positive Familial Isolated Pituitary Adenoma (FIPA): A Kindred-Based Overview

Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences.

Pituitary adenomas in young patients: when should we consider a genetic predisposition?

Pituitary gigantism: Causes and clinical characteristics

Predictors and rates of treatment-resistant tumor growth in acromegaly.

Primary hypertrophic osteoarthropathy due to a novel SLCO2A1 mutation masquerading as acromegaly

Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients